Statement Of Changes In Equity [Abstract]

Biocartis Group NV - Filing #3123162

Concept	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	526,405 EUR	5,572 EUR	—	—	33,897 EUR	—	33,897 EUR	711,874 EUR	6,862 EUR	220,657 EUR	—	—	455,343 EUR	—	36,824 EUR	220,657 EUR	—	—	711,874 EUR	6,102 EUR	5,153 EUR	—	36,824 EUR	—	84,480 EUR	5,291 EUR	698,027 EUR	84,480 EUR	392,259 EUR	4,670 EUR	220,668 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	71,472 EUR	—	—	—	—	—	—	71,472 EUR	71,472 EUR	—	62,934 EUR	—	—	62,934 EUR	—	—	—	—	—	—	62,934 EUR	—	—	—	—	—	—	—
Comprehensive income	—	—	419,000 EUR	71,481 EUR	—	—	—	—	—	—	71,481 EUR	71,062 EUR	—	62,945 EUR	—	—	63,084 EUR	—	—	—	—	139,000 EUR	—	62,945 EUR	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	—	760,000 EUR	—	760,000 EUR	—	—	—	—	760,000 EUR	—	—	1,432 EUR	—	—	—	1,432 EUR	—	—	—	—	—	1,432 EUR	—	—	—	—	—	—	—